PSNY Financial Statements & Analysis
Complete financial statements for PSNY including income statement, balance sheet, and cash flow statement. Analyze PSNY's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
Income Statement
Revenue
50.3% ↑
Net Income
-15.0% ↓
Gross Margin
17.7% ↑
Operating Margin
27.1% ↑
Balance Sheet
Current Ratio
-10.7% ↓
Debt to Equity
15.9% ↓
Asset Turnover
55.1% ↑
Cash Flow
Operating Cash Flow
7.7% ↑
Net Cash Flow
1547.1% ↑
Free Cash Flow
-1.6% ↓
Cash Flow to Debt
28.7% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2024 | 2025 | Change | Impact |
|---|---|---|---|---|
| Revenue | 2.03B | 3.06B | 50.3% | |
| Gross Profit | -876.17M | -1.08B | 23.7% | |
| Operating Income | -1.81B | -1.99B | 9.6% | |
| Net Income | -2.05B | -2.36B | 15.0% | |
| EPS | -29.10 | -25.48 | 12.4% | |
| EBITDA | -1.67B | -1.93B | 15.9% | |
| Gross Margin | -43.07% | -35.44% | 17.7% | |
| Operating Margin | -89.14% | -64.96% | 27.1% | |
| Net Income Margin | -100.77% | -77.08% | 23.5% | |
| R&D Expenses | 38.35M | 77.64M | 102.4% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 3.06B | 2.03B | 2.38B | — | — |
| Gross Profit | -1.08B | -876.17M | -413.08M | — | — |
| Operating Income | -1.99B | -1.81B | -1.48B | — | — |
| Net Income | -2.36B | -2.05B | -1.19B | — | — |
| EPS | -25.48 | -29.10 | -17.10 | — | — |
| EBITDA | -1.93B | -1.67B | -826.89M | — | — |
| Gross Margin | -35.44% | -43.07% | -17.37% | — | — |
| Operating Margin | -64.96% | -89.14% | -62.22% | — | — |
| Net Income Margin | -77.08% | -100.77% | -50.23% | — | — |
| R&D Expenses | 77.64M | 38.35M | 158.41M | — | — |
Financial Metrics
Want to dive deeper into PSNY's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics
